| NAME OF THE PROJECT | : Doxazosin Mesilate |
| PRODUCT NAME | : Doxazosin EP Impurity - B |
| CODE & CAT NO | : LP - 5200-03-002 |
| MOLECULAR FORMULA | : C13H16N2O3 |
| MOLECULAR WEIGHT | : 248.27 |
| CAS NO | : 70918-74-0(HCl salt)70918-00-2(Free Base) |
| CHEMICAL NAME | : 1-[(2RS)-2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl] piperazine |
| CAT NO | : LP - 5200-01-001 |
| CAS NO | : 77883-43-3 |
| Mol.F | : C24H29N5O8S |
| Mol.Wt. | : 547.58 |
| CAT NO | : LP - 5200-03-001 |
| CAS NO | : 3663-80-7 |
| Mol.F | : C9H8O4 |
| Mol.Wt. | : 180.16 |
| CAT NO | : LP - 5200-03-002 |
| CAS NO | : 70918-74-0,70918-00-2 |
| Mol.F | : C13H16N2O3 |
| Mol.Wt. | : 248.27 |
| CAT NO | : LP - 5200-03-003 |
| CAS NO | : 617677-53-9 |
| Mol.F | : C22H22N2O6 |
| Mol.Wt. | : 410.42 |
| CAT NO | : LP - 5200-03-004 |
| CAS NO | : 28888-44-0 |
| Mol.F | : C10H10N2O4 |
| Mol.Wt. | : 222.2 |
| CAT NO | : LP - 5200-03-005 |
| CAS NO | : 27631-29-4 |
| Mol.F | : C10H8Cl2N2O2 |
| Mol.Wt. | : 259.09 |
| CAT NO | : LP - 5200-03-006 |
| CAS NO | : 23680-84-4 |
| Mol.F | : C10H10ClN3O2 |
| Mol.Wt. | : 239.66 |
| CAT NO | : LP-5200-03-007 |
| CAS NO | :60547-97-9 |
| Mol.F | : C14H19N5O2 |
| Mol.Wt. | : 289.33 |
| CAT NO | : LP-5200-03-008 |
| CAS NO | : 102839-00-9 |
| Mol.F | : C24H28N8O4 |
| Mol.Wt. | : 492.53 |
| CAT NO | : LP-5200-03-002 |
| CAS NO | : 70918-74-0 |
| Mol.F | : C13H17ClN2O3 |
| Mol.Wt. | : 284.74 |
| CAT NO | : LP-5200-03-004 |
| CAS NO | : 28888-44-0 |
| Mol.F | : C10H10N2O4 |
| Mol.Wt. | : 222.2 |
| CAT NO | : LP-5200-03-006 |
| CAS NO | :23680-84-4 |
| Mol.F | : C10H10ClN3O2 |
| Mol.Wt. | : 239.65 |
| CAT NO | : LP-5200-03-001 |
| CAS NO | : 3663-80-7 |
| Mol.F | : C9H8O4 |
| Mol.Wt. | : 180.16 |
| CAT NO | : LP-5200-03-005 |
| CAS NO | : 27631-29-4 |
| Mol.F | : C10H8Cl2N2O2 |
| Mol.Wt. | : 259.09 |
| CAT NO | : LP-5200-03-003 |
| CAS NO | : 617677-53-9 |
| Mol.F | : C22H22N2O6 |
| Mol.Wt. | : 410.42 |
CATEGORY : Doxazosin Mesilate
TOTAL PRODUCTS : 15
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
